IP Library Granted Patent US 11,873,316
Granted Patent B2
US 11,873,316 · App. 16/463,328 · Granted Jan 16, 2024

Compositions and methods for phosphoramidite and oligonucleotide synthesis

Inventors: David Charles Donnell Butler (Medford, MA); Pachamuthu Kandasamy (Belmont, MA); Subramanian Marappan (Acton, MA); Ik-Hyeon Paik (Needham, MA); Jayakanthan Kumarasamy (Arlington, MA); Gopal Reddy Bommineni (Belmont, MA)
Assignee: WAVE LIFE SCIENCES LTD.
C07H1/06C07H19/10C07H19/207C07H21/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,873,316
App. No.
16/463,328
Granted
Jan 16, 2024
Kind
B2
Abstract

The present disclosure, among other things, provides technologies for oligonucleotide synthesis. In some embodiments, the present disclosure provides phosphoramidites and methods for synthesis thereof. In some embodiments, provided methods provides higher yields and/or purities. In some embodiments, provided methods remove byproducts without contact with an aqueous solution.

Claims (37)

1. A method for preparing a phosphoramidite, comprising steps of:

a) providing a preparation comprising a phosphoramidite product and one or more reaction byproducts of the synthesis of the phosphoramidite; and

b) performing a filtration step on the preparation to provide a filtrate, wherein the filtrate contains a reduced level of the one or more reaction byproducts relative to the product as compared to that level present in the preparation prior to the filtration step,

wherein:

after the phosphoramidite product is formed, no solution comprising the phosphoramidite product is contacted with water of more than 100 mole equivalents of the phosphoramidite; and

the phosphoramidite has the structure of formula I:

wherein:

BA is

 wherein R is hydrogen or optionally substituted C 1-6 aliphatic;

SU is

R 5 s is R′ or —OR′;

wherein:

(1) R 2s is —F or —OCH 2 CH 2 OMe, and

 or

(2) R 2s is —F, —H, or —OCH 2 CH 2 OMe, and

each R′ is independently —R, —C(O)R, —CO 2 R, or —SO 2 R, or:

two or more R′ are taken together with their intervening atoms to form an optionally substituted monocyclic, bicyclic or polycyclic, saturated, partially unsaturated, or aryl 3-30 membered ring having, in addition to the intervening atoms, 0-10 heteroatoms independently selected from oxygen, nitrogen, sulfur, phosphorus and silicon; and

each R is independently hydrogen, or an optionally substituted group selected from C 1-30 aliphatic, C 1-30 heteroaliphatic having 1-10 heteroatoms independently selected from oxygen, nitrogen, sulfur, phosphorus and silicon, C 6-30 aryl, a 5-30 membered heteroaryl ring having 1-10 heteroatoms independently selected from oxygen, nitrogen, sulfur, phosphorus and silicon, and a 3-30 membered heterocyclic ring having 1-10 heteroatoms independently selected from oxygen, nitrogen, sulfur, phosphorus and silicon.

2. The method of claim 1 , wherein the preparation comprises a solution and one or more solids.

3. The method of claim 2 , wherein the solution comprises the phosphoramidite product.

4. The method of claim 3 , wherein the one or more solids comprise one or more reaction byproducts.

5. The method of claim 4 , wherein R 5S is DMTrO-.

6. The method of claim 5 , wherein R 2s is —H.

7. The method of claim 4 , comprising purifying the phosphoramidite product using silica gel column chromatography, wherein the silica gel is treated with an anhydrous acetonitrile.

8. The method of claim 5 , wherein R 2s is —F.

9. The method of claim 8 , wherein

10. The method of claim 8 , wherein

11. The method of claim 5 , wherein R 2s is —OCH 2 CH 2 OMe.

12. The method of claim 11 , wherein

13. The method of claim 11 , wherein BA is

14. The method of claim 4 , wherein BA is

in which R is C 1-6 alkyl.

15. The method of claim 4 , wherein BA is

in which R is isopropyl.

16. The method of claim 1 , wherein the prepared phosphoramidite has a purity of 90% or more.

17. The method of claim 1 , wherein the prepared phosphoramidite has a purity of 95% or more.

18. The method of claim 1 , wherein the prepared phosphoramidite has a purity of 96% or more.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 10, 2019
From: BUTLER, DAVID CHARLES DONNELL; KANDASAMY, PACHAMUTHU; MARAPPAN, SUBRAMANIAN; PAIK, IK-HYEON; KUMARASAMY, JAYAKANTHAN; BOMMINENI, GOPAL REDDY
To: WAVE LIFE SCIENCES LTD.
Reel/Frame 049719/0034 →
Continuity (2)
Provisional Application 62426079 · Nov 23, 2016
Related Publication 20190375774A1 · Dec 12, 2019
Cited By (11)
US 12,391,942 US 12,403,156 US 12,428,442 US 12,435,105 US 12,473,321 US 12,486,505 US 12,552,743 US 12,583,883 US 12,590,115 US 12,637,672 US 12,674,168